TOMDFライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 02:07):

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States...

Stats
本日の出来高	1 500.00
平均出来高	6.06M
時価総額	1 408.00
EPS	$-0.00467 ( 2022-11-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-28	Commissiong Gerald	Buy	5 000 000	Ordinary Shares
2022-08-24	Commissiong Gerald	Buy	1 000 000	Ordinary Shares
2021-06-30	Commissiong Gerald	Buy	1 051 480	Ordinary Shares
2021-04-01	Strategic Investment Holdings, Llc	Sell	150 000	Common Stock
2021-04-01	Strategic Investment Holdings, Llc	Sell	100 000	Common Stock

INSIDER POWER
100.00
Last 16 transactions
Buy: 55 759 665 \| Sell: 3 671 864

Todos Medical Ltd. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Todos Medical Ltd. 財務諸表

Annual	2022
収益:	$7.70M
総利益:	$4.31M (56.01 %)
EPS:	$-0.0175

FY	2022
収益:	$7.70M
総利益:	$4.31M (56.01 %)
EPS:	$-0.0175

FY	2021
収益:	$12.23M
総利益:	$4.38M (35.84 %)
EPS:	$-0.0600

FY	2020
収益:	$5.21M
総利益:	$1.39M (26.68 %)
EPS:	$-0.110

Financial Reports:

No articles found.

Todos Medical Ltd.

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.